Ask AI
Alexander Craig Mackinnon, Jr.

Alexander Craig Mackinnon, Jr., MD, PhD, MSHA

Executive Vice Chair & Robert B. Adams Endowed Professor
Professor of Pathology
Director, Division of Genomic Diagnostics & Bioinformatics
Department of Pathology
The University of Alabama at Birmingham Heersink School of Medicine
Birmingham, Alabama

Explore Activities by Alexander Craig Mackinnon, Jr.

Title
Format
Credit Type
Credits
Best Practices in Testing and Treatment for Advanced ALK-Positive NSCLC and Overcoming Challenges to Implementation in Clinical Practice

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Managing Advanced ALK-Positive Non-Small-Cell Lung Cancer: Considerations for Community Practitioners

Content Format:

PDF

Credit Type:

--

Credits:

--
Addressing Key Questions: Expert Insights to Guide Pathologist-Informed Clinical Decisions in HER2-Expressing or Amplified Solid Tumors

Content Format:

Video

Credit Type:

ABIM MOC | ABPath MOC | AMA

Credits:

1.00
Expert Insights Into HER2 Testing for Advanced Breast, GI, and Lung Cancers

Content Format:

Slideset

Credit Type:

--

Credits:

--
FAQs: New Directions in Biomarker Testing in the Management of NSCLC

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Trastuzumab Deruxtecan for Our Patients With HER2 Mutation–Positive Advanced NSCLC

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
FAQs: Importance of Biomarker Testing in NSCLC

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Testing Before Treating: Molecular Determinants of Optimal Therapy for NSCLC

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
What Must Be Tested in NSCLC Today and Likely Tomorrow

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Biomarker Testing to Optimize NSCLC Care: Multidisciplinary Perspectives

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
Biomarker Testing in NSCLC

Content Format:

Slideset Download

Credit Type:

--

Credits:

--